- World Pharma News Home » Corporate » Nycomed intends to move chemical production to Indian joint venture
(a free service delivered by FeedBurner)
Nycomed and Cadila Healthcare have signed a letter agreement with the intent to amend their existing joint venture agreement to include the chemical production of active pharmaceutical ingredients (APIs) by the joint venture company Zydus Nycomed in India. Based on this agreement, Nycomed plans to transfer the current chemical production from the sites in Linz (Austria) and Singen (Germany) to the new joint venture within the next three to four years. Over this period, a maximum of 200 positions of about 1,400 people working in Singen and Linz might be affected.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments